Credit Suisse’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$19.3M Sell
129,346
-46,630
-26% -$6.97M 0.02% 639
2023
Q4
$33.7M Buy
175,976
+10,564
+6% +$2.02M 0.03% 498
2023
Q3
$29.3M Sell
165,412
-2,724
-2% -$482K 0.03% 526
2023
Q2
$31.9M Buy
168,136
+36,063
+27% +$6.85M 0.03% 523
2023
Q1
$26.5M Buy
132,073
+5,994
+5% +$1.2M 0.03% 578
2022
Q4
$30M Buy
126,079
+12,570
+11% +$2.99M 0.03% 550
2022
Q3
$22.7M Sell
113,509
-1,184
-1% -$237K 0.03% 612
2022
Q2
$16.7M Sell
114,693
-4,917
-4% -$717K 0.02% 742
2022
Q1
$19.5M Buy
119,610
+6,071
+5% +$991K 0.02% 774
2021
Q4
$19.3M Sell
113,539
-44,147
-28% -$7.49M 0.01% 810
2021
Q3
$29.8M Sell
157,686
-27,625
-15% -$5.22M 0.02% 657
2021
Q2
$31.4M Sell
185,311
-41,886
-18% -$7.1M 0.02% 668
2021
Q1
$32.1M Buy
227,197
+52,963
+30% +$7.48M 0.02% 677
2020
Q4
$22.6M Buy
174,234
+12,820
+8% +$1.67M 0.01% 781
2020
Q3
$23.5M Sell
161,414
-5,828
-3% -$849K 0.01% 692
2020
Q2
$24.8M Sell
167,242
-42,555
-20% -$6.3M 0.02% 653
2020
Q1
$22.8M Buy
209,797
+35,051
+20% +$3.82M 0.02% 613
2019
Q4
$20.1M Sell
174,746
-17,896
-9% -$2.06M 0.01% 764
2019
Q3
$15.5M Sell
192,642
-99,736
-34% -$8.02M 0.01% 805
2019
Q2
$21.2M Buy
292,378
+10,046
+4% +$729K 0.02% 686
2019
Q1
$26.4M Sell
282,332
-7,913
-3% -$739K 0.02% 559
2018
Q4
$21.2M Buy
290,245
+42,054
+17% +$3.07M 0.02% 623
2018
Q3
$21.7M Buy
248,191
+34,302
+16% +$3M 0.02% 693
2018
Q2
$21.1M Sell
213,889
-98,641
-32% -$9.72M 0.02% 681
2018
Q1
$37.2M Buy
312,530
+86,693
+38% +$10.3M 0.03% 472
2017
Q4
$28.7M Buy
225,837
+66,911
+42% +$8.5M 0.03% 548
2017
Q3
$18.7M Sell
158,926
-21,817
-12% -$2.56M 0.02% 700
2017
Q2
$14.4M Sell
180,743
-67,621
-27% -$5.39M 0.01% 833
2017
Q1
$12.7M Buy
248,364
+69,697
+39% +$3.57M 0.01% 925
2016
Q4
$6.69M Sell
178,667
-40,003
-18% -$1.5M 0.01% 1247
2016
Q3
$14.8M Buy
218,670
+9,375
+4% +$635K 0.01% 862
2016
Q2
$11.6M Sell
209,295
-25,173
-11% -$1.4M 0.01% 946
2016
Q1
$14.7M Buy
234,468
+44,957
+24% +$2.82M 0.02% 809
2015
Q4
$17.8M Sell
189,511
-17,580
-8% -$1.66M 0.02% 784
2015
Q3
$16.6M Sell
207,091
-102,839
-33% -$8.26M 0.02% 792
2015
Q2
$37.2M Buy
309,930
+37,976
+14% +$4.55M 0.04% 506
2015
Q1
$28.4M Buy
271,954
+22,482
+9% +$2.35M 0.03% 597
2014
Q4
$24.2M Buy
249,472
+77,754
+45% +$7.54M 0.02% 677
2014
Q3
$13.4M Sell
171,718
-24,846
-13% -$1.94M 0.01% 978
2014
Q2
$12.4M Buy
196,564
+47,586
+32% +$3.01M 0.01% 1054
2014
Q1
$10M Buy
148,978
+26,967
+22% +$1.81M 0.01% 1093
2013
Q4
$7.85M Buy
122,011
+25,608
+27% +$1.65M 0.01% 1233
2013
Q3
$6.17M Sell
96,403
-21,126
-18% -$1.35M 0.01% 1237
2013
Q2
$3.64M Buy
+117,529
New +$3.64M ﹤0.01% 1565